Breakthrough Research: This Medical Company Presents Innovative Therapy

Unprecedented Anti-Tumor Activity Reported by BriaCell at 2023 SITC Annual Meeting.

BriaCell Therapeutics Corp. has recently made a significant breakthrough in the field of cancer immunotherapies. The company presented its latest findings at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting, where it reported unprecedented anti-tumor activity of its next-generation personalized breast and prostate cancer immunotherapie…